NeuBase Therapeutics, Inc. Operating Lease Cost
NeuBase Therapeutics, Inc. reported Operating Lease Cost of $943.22 thousand for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-12-21
- NeuBase Therapeutics, Inc. operating lease, cost for the quarter ending 2021-12-31 was $216.20K.
- NeuBase Therapeutics, Inc. operating lease, cost for the quarter ending 2021-09-30 was $216.20K.
- NeuBase Therapeutics, Inc. operating lease, cost for the quarter ending 2021-06-30 was $144.14K.
- NeuBase Therapeutics, Inc. operating lease, cost for the quarter ending 2020-12-31 was $0.00.
- NeuBase Therapeutics, Inc. operating lease, cost for fiscal 2022 was $943.22K, a 161.76% increase from fiscal 2021.
- NeuBase Therapeutics, Inc. operating lease, cost for fiscal 2021 was $360.34K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | $943.22K 10-K · filed 2022-12-21 | ||||
| 2021-12-31 | $216.20K 10-Q · filed 2022-02-11 | $432.41K derived: sum of 2 quarters · filed 2022-12-21 | $576.54K derived: sum of 3 quarters · filed 2022-12-21 | ||
| 2021-09-30 | $216.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $360.34K derived: sum of 2 quarters · filed 2022-12-21 | $360.34K 10-K · filed 2022-12-21 | $360.34M 10-K · filed 2021-12-23 | |
| 2021-06-30 | $144.14K 10-Q · filed 2021-08-13 | $144.14K 10-Q · filed 2021-08-13 | |||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-11 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 |